Targeting Neuropathogenesis of Altered Mental Status to Improve Survival in Cryptococcal Meningitis

项目摘要/摘要 马赫萨·阿巴西博士是世界卫生组织传染病科医学助理教授。 明尼苏达大学。在过去的六年里，她一直从事临床研究，专注于艾滋病毒- 乌干达的相关神经感染。她的长期目标是成为一名独立的临床研究人员 重点是改善神经感染的结果。她的职业发展计划建议在 培训：1)神经学技术(脑电、神经放射学和神经认知评估)，2)实验室 与代谢组学应用相关的技术，以及4)生物统计学，重点分析 生物样品中的代谢物。 研究：隐球菌性脑膜炎占全球艾滋病毒/艾滋病相关死亡的15%，是全球最大的 在非洲，成人脑膜炎的常见原因。当时的精神状态改变(从精神错乱到昏迷) 隐球菌性脑膜炎的诊断始终是死亡率增加的独立预测因素。尽管 反复的研究证实了精神状态改变和死亡之间的这种强烈联系，有一种 根本上缺乏对导致急性精神改变的确切神经异常的了解 它的现状、它对死亡率增加的贡献，以及管理的最佳做法。 这项建议的目标是确定导致智力改变的神经异常。 了解这一状况如何有助于增加隐球菌死亡率。最重要的假设 是隐球菌性脑膜炎伴其颅内压升高导致脑缺氧，异常 中枢神经系统(CNS)的电活动和生化变化可以通过 脑代谢产物脑脊液分析和增强的临床监测与脑氧仪和脑电图。这 该提案旨在：1)确定患有隐球菌性脑膜炎的艾滋病毒感染者是否出现了改变 确诊时的精神状态(格拉斯哥昏迷量表(GCS)和15)具有可测量的潜在神经学基础 脑能量代谢异常和损害(即氧化代谢不足) 与精神状态正常的人(GCS=15)进行比较；以及2)确定是否实施标准化 临床干预可在3分钟内逆转神经异常，改善大脑能量代谢 诊断天数，并降低表现为隐球菌性脑膜炎的艾滋病毒感染者30天的死亡率 精神状态改变(GCS&lt；15)。上述目标的结果将揭开以前未知的面纱 导致隐球菌性脑膜炎患者精神状态改变的病理生理机制。在中国的培训 阿巴西博士将获得的神经感染、代谢组学应用和生物统计学将为未来提供信息 致力于了解各种神经感染的神经病理并寻找证据的提案- 致力于提高存活率的干预措施。

Project Summary / Abstract Dr. Mahsa Abassi is an Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Minnesota. Over the past six years, she has been engaged in clinical research, focusing on HIV- related neuroinfections in Uganda. Her long-term objective is to become an independent clinical researcher with an emphasis on improving outcomes in neuroinfections. Her career development plan proposes mentored training in: 1) neurologic techniques (EEGs, neuroradiology, and neurocognitive assessment), 2) laboratory techniques related to metabolomics applications, and 4) biostatistics with an emphasis of analyzing metabolites in biologic samples. Research: Cryptococcal meningitis accounts for 15% of HIV/AIDS-related deaths globally and is the most common cause of adult meningitis in Africa. Altered mental status (ranging from delirium to coma) at the time of cryptococcal meningitis diagnosis is consistently an independent predictor of increased mortality. Despite repeated studies confirming this strong association between altered mental status and death, there is a fundamental lack of understanding into the exact neurological abnormalities leading to acute altered mental status, its contributions to increased mortality, and the best practices for management. The objective of this proposal is to identify the neurological abnormalities that contribute to altered mental status and to understand how this contributes to increased cryptococcal mortality. The overarching hypothesis is that cryptococcal meningitis with its increased intracranial pressure leads to cerebral hypoxia, abnormal electrical activity, and biochemical changes in the central nervous system (CNS) that can be detected through brain metabolite CSF analysis and enhanced clinical monitoring with cerebral oximetry and EEGs. This proposal aims to: 1) determine if HIV-infected persons with cryptococcal meningitis presenting with altered mental status (Glasgow Coma Scale (GCS) <15) at diagnosis have measurable underlying neurological abnormalities and impairments in cerebral energy metabolism (i.e. insufficient oxidative metabolism) as compared to persons with normal mental status (GCS=15); and 2) determine if implementation of standardized clinical interventions can reverse neurological abnormalities and improve cerebral energy metabolism within 3 days of diagnosis, and reduce 30-day mortality in HIV-infected persons with cryptococcal meningitis presenting with altered mental status (GCS<15). Results of the above aims will shed light into previously unknown pathophysiologic mechanisms that lead to altered mental status in cryptococcal meningitis. The training in neuroinfections, metabolomics applications, and biostatistics that Dr. Abassi will obtain will inform future proposals dedicated to understanding the neuropathology of various neuroinfections and finding evidence- based interventions dedicated to improving survival.